Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002316165 | SCV000847786 | uncertain significance | Inborn genetic diseases | 2016-09-06 | criteria provided, single submitter | clinical testing | The p.R1337Q variant (also known as c.4010G>A), located in coding exon 16 of the ARID1B gene, results from a G to A substitution at nucleotide position 4010. The arginine at codon 1337 is replaced by glutamine, an amino acid with highly similar properties. This variant was not reported in population based cohorts in the following databases: Database of Single Nucleotide Polymorphisms (dbSNP), NHLBI Exome Sequencing Project (ESP), and 1000 Genomes Project. In the ESP, this variant was not observed in 6499 samples (12998 alleles) with coverage at this position. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this variant remains unclear. |
Revvity Omics, |
RCV003141720 | SCV003826928 | uncertain significance | Coffin-Siris syndrome 1 | 2021-08-06 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004535780 | SCV004117053 | uncertain significance | ARID1B-related disorder | 2023-09-12 | criteria provided, single submitter | clinical testing | The ARID1B c.4010G>A variant is predicted to result in the amino acid substitution p.Arg1337Gln. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0061% of alleles in individuals of East Asian descent in gnomAD, including two individuals from the non-neuro sub-population (http://gnomad.broadinstitute.org/variant/6-157517446-G-A). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |
Labcorp Genetics |
RCV005092072 | SCV005828451 | benign | not provided | 2024-05-29 | criteria provided, single submitter | clinical testing |